Most Recent Articles by Diana Ernst
Both gabapentin and opioids are commonly prescribed for the treatment of pain, making the likelihood of these two agents being prescribed together high.
The FDA has approved Lyrica CR, a once-daily treatment for the management of neuropathic pain associated with diabetic peripheral neuropathy and the management of postherpetic neuralgia.
A recently published case series describes a new subtype of chronic daily headache that appears to be associated with elevated cerebrospinal fluid pressure.
The FDA has approved Durolane for the treatment of pain associated with knee osteoarthritis, which relieved pain and restored function for up to 6 months in patients.
The FDA approved Duzallo, a fixed-dose tablet combining lesinurad and allopurinol, for the treatment of uncontrolled gout.
More Articles by Diana Ernst
Clinical Pain Advisor Articles
- Virtual Reality for Pain Relief: Understanding the Underlying Mechanisms
- Vibrating Gloves Significantly Reduce Osteoarthritis-Related Hand Pain
- Neuroimaging for Chronic Pain: IASP Consensus Statement
- Neuroinflammation in Neuropathic Pain Indicated by Elevated Levels of Proinflammatory Chemokines in CSF
- Hypertension in Chronic Pain: Risk Factors
- Liposomal Bupivacaine Effective for Shoulder Arthroplasty-Related Pain
- Reducing the P-Value for Statistical Significance to Improve the Quality of Research?
- FDA's Strategies for Managing Patients Taking CNS Depressants and Opioids
- Electrotherapy, Acupuncture May Decrease Pain Following Total Knee Arthroplasty
- Low-Dose Oromucosal Ibuprofen Effective for Relieving Sore Throat
- Survey Finds Teens Divided on Beliefs and Attitudes of Prescription Drug Abuse
- HIV-Positive Patients Experience Frequent Headaches
- Low-Dose Perineural Dexamethasone Prolongs Effects of Brachial Plexus Nerve Block
- Business Savvy Tips for Buying a Practice
- Diphenhydramine Decreases Pain During Colonoscopy for Chronic Opioid Users